Ozempic Approved for Diabetic Kidney Disease

[ad_1]

(MedPage Today) — The FDA approved semaglutide (Ozempic) to reduce the risk of kidney disease worsening, kidney failure, and death due to cardiovascular disease in adults with type 2 diabetes and chronic kidney disease (CKD), making it the only…

[ad_2]

Source link : https://www.medpagetoday.com/nephrology/diabetes/113985

Author :

Publish date : 2025-01-28 21:45:15

Copyright for syndicated content belongs to the linked Source.